scholarly journals The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

2011 ◽  
Vol 9 (1) ◽  
Author(s):  
Eric Benoit ◽  
Thomas F O'Donnell ◽  
Mark D Iafrati ◽  
Enrico Asher ◽  
Dennis F Bandyk ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Critical Limb Ischemia ◽  
Trial Design ◽  
Cellular Therapy ◽  
Outcome Measure ◽  
Clinical Trial Design ◽  
Limb Ischemia

scholarly journals Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia

2009 ◽  
Vol 50 (6) ◽  
pp. 1462-1473.e3 ◽  
Author(s):  
Michael S. Conte ◽  
Patrick J. Geraghty ◽  
Andrew W. Bradbury ◽  
Nathanael D. Hevelone ◽  
Stuart R. Lipsitz ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Critical Limb Ischemia ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Limb Ischemia ◽  
Performance Goals ◽  
Objective Performance

scholarly journals Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: Implications for clinical trial design

2008 ◽  
Vol 47 (5) ◽  
pp. 995-1000 ◽  
Author(s):  
Carlos A. Rueda ◽  
Mark R. Nehler ◽  
Darryl J. Perry ◽  
Robert B. McLafferty ◽  
Ivan P. Casserly ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Critical Limb Ischemia ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Limb Ischemia ◽  
Artery Disease

scholarly journals X-change symposium: status and future of modern radiation oncology—from technology to biology

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Stefanie Corradini ◽  
Maximilian Niyazi ◽  
Dirk Verellen ◽  
Vincenzo Valentini ◽  
Seán Walsh ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Radiation Oncology ◽  
Trial Design ◽  
Rapid Development ◽  
Clinical Trial Design ◽  
Current Status ◽  
Treatment Modalities ◽  
Special Treatment ◽  
Image Guided Radiotherapy

AbstractFuture radiation oncology encompasses a broad spectrum of topics ranging from modern clinical trial design to treatment and imaging technology and biology. In more detail, the application of hybrid MRI devices in modern image-guided radiotherapy; the emerging field of radiomics; the role of molecular imaging using positron emission tomography and its integration into clinical routine; radiation biology with its future perspectives, the role of molecular signatures in prognostic modelling; as well as special treatment modalities such as brachytherapy or proton beam therapy are areas of rapid development. More clinically, radiation oncology will certainly find an important role in the management of oligometastasis. The treatment spectrum will also be widened by the rational integration of modern systemic targeted or immune therapies into multimodal treatment strategies. All these developments will require a concise rethinking of clinical trial design. This article reviews the current status and the potential developments in the field of radiation oncology as discussed by a panel of European and international experts sharing their vision during the “X-Change” symposium, held in July 2019 in Munich (Germany).

The role of sampling in clinical trial design

2011 ◽  
Vol 21 (3) ◽  
pp. 243-251 ◽  
Author(s):  
Merton Krause ◽  
Wolfgang Lutz ◽  
Jan R. Boehnke
Keyword(s):  
Clinical Trial ◽  
Trial Design ◽  
Clinical Trial Design

Tu-W27:1 Clinical trial design & management: The role of PPAR-alpha agonists in prevention of CVD

2006 ◽  
Vol 7 (3) ◽  
pp. 174
Author(s):  
A.C. Keech ◽  
R.J. Simes ◽  
FIELD Study Investigators
Keyword(s):  
Clinical Trial ◽  
Trial Design ◽  
Clinical Trial Design ◽  
Design Management ◽  
Ppar Alpha

Integrating radiomics into clinical trial design

2019 ◽  
Vol 63 (4) ◽  
Author(s):  
Jessica J. Waninger ◽  
Michael D. Green ◽  
Catherine Cheze Le Rest ◽  
Benjamin Rosen ◽  
Issam El Naqa
Keyword(s):  
Clinical Trial ◽  
Trial Design ◽  
Clinical Trial Design
Sign in / Sign up

Export Citation Format

Share Document